bioAffinity Technologies, Inc. (BIAF)
NASDAQ: BIAF · Real-Time Price · USD
1.190
+0.130 (12.26%)
At close: Mar 10, 2026, 4:00 PM EDT
1.160
-0.030 (-2.52%)
After-hours: Mar 10, 2026, 7:59 PM EDT

bioAffinity Technologies Revenue

bioAffinity Technologies had revenue of $1.45M in the quarter ending September 30, 2025, a decrease of -38.48%. This brings the company's revenue in the last twelve months to $6.78M, down -27.66% year-over-year. In the year 2024, bioAffinity Technologies had annual revenue of $9.36M with 269.68% growth.

Revenue (ttm)
$6.78M
Revenue Growth
-27.66%
P/S Ratio
0.79
Revenue / Employee
$118,890
Employees
57
Market Cap
5.35M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20249.36M6.83M269.68%
Dec 31, 20232.53M2.53M52,627.44%
Dec 31, 20224.80K--
Dec 31, 2021---
Dec 31, 2020---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Inotiv514.03M
MDxHealth107.88M
FONAR106.03M
Exagen66.58M
XWELL29.52M
Precipio22.80M
iSpecimen3.35M
Mainz Biomed659.94K
Revenue Rankings